# US 2013/0158241 A1 · Process for Preparing Crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic Acid and Use for Production of Primovist®

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158241 A1
- Document ID: US20130158241A1
- Status: Published application
- Kind: A1
- Application number: 13/703,579
- Filed: 2011-06-06
- Published: 2013-06-20
- Earliest claimed: 2010-06-11
- Assignees: Bayer Intellectual Property GmbH
- Inventors: Johannes Platzek; Wilhelm Trentmann
- Web page: https://patentgrep.com/patent/US20130158241A1

## CPC

- C07C 227/18: by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C 227/42: Crystallisation
- C07C 229/16: to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
- C07C 229/26: having more than one amino group bound to the carbon skeleton, e.g. lysine
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The invention relates to a method for producing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of the formula I by saponifying 3,6,9-triaza-3,6,9-tris(tert-butoxycarbonylmethyl)-4-(4-ethoxybenzyl)-undecanedioic acid di-tert-butyl ester of the formula II in an aqueous alkali metal hydroxide solution and using 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of the formula I for producing the gadolinium complex of 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid [(Gd-EOB-DTPA)=Primovist®].

## Claims

### Claim 1

1) Method for producing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of formula I,
characterized in that 3,6,9-triaza-3,6,9-tris-(tert-butoxy-carbonylmethyl)-4-(4-ethoxy-benzyl)undecanedioic acid di-tert-butyl ester of formula II
is hydrolysed with an aqueous alkali metal hydroxide solution, concentrated, a residue is dissolved in water and a resultant solution is acidified and filtered from a precipitate.

### Claim 2

2) Method for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of formula I
characterized in that 3,6,9-triaza-3,6,9-tris(tert-butoxycarbonylmethyl)-4-(4-ethoxybenzyl)undecanedioic acid di-tert-butyl ester of formula II
is dissolved in a lower alcohol, hydrolysed with an aqueous alkali metal hydroxide solution, a resultant reaction mixture is concentrated, a residue dissolved in water and a resultant solution acidified by slow addition of an aqueous inorganic acid and filtered from a precipitate.

### Claim 3 (depends on 1)

3) Method for producing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid according to claim 1, characterized in that resultant crude crystals are dissolved in 4- to 6-times an amount of boiling water and then cooled with a cooling rate of a maximum of 10° C. per hour.

### Claim 4

4) Use of 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of formula I
for producing a gadolinium complex of 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid (Gd-EOB-DTPA).

### Claim 5

5) Use of crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid of formula I
for producing a galenical formulation of the gadolinium complex of 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid (Gd-EOB-DTPA).

### Claim 6

6) 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid in a purity of greater than 99%.

### Claim 7 (depends on 2)

Method for producing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid according to claim 2, characterized in that resultant crude crystals are dissolved in 4- to 6-times an amount of boiling water and then cooled with a cooling rate of a maximum of 10° C. per hour.
